搜尋結果
First Zantac Cancer Case to Go to Trial Ends in Win for Drugmakers
Bloomberg· 22 小時前Drugmakers GSK Plc and Boehringer Ingelheim GmbH persuaded a Chicago jury to reject a woman’s ...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's ...
CNBC· 24 小時前Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall ...
Could this advance in radionuclide therapy help late-stage cancer patients?
South China Morning Post· 8 小時前The university said it was the first original research paper in the field of radionuclide ...
Ex-finance chief Leung’s firm buys Hong Kong cancer centre as it expands in GBA
South China Morning Post· 18 小時前“Through this partnership, surgeons, oncologists, and other allied health specialists will ...
New Kate Middleton Portrait Released—But Some Think It Doesn’t Look Like Her
Forbes· 2 日前Uzor, whose painting was released about two months after news that Kate was undergoing cancer t ...
Zantac not a cause of woman’s cancer, jury says in first trial over drug
Reuters· 21 小時前A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued ...
Hongkonger who donated HK$800,000 to children’s cancer fund while terminally ill has died
Hong Kong Free Press· 1 日前A 28-year-old Hong Kong man who donated HK$800,000 to a children’s cancer fund while he was ...
Council Post: Knowing When A Nonprofit Can Reach Further
Forbes· 11 小時前In 2007, I founded the Isabella Santos Foundation (ISF) in honor of my daughter, who was ...
U.S. FDA advisers back approval for Guardant's blood-based cancer test
Reuters· 18 小時前, opens new tab blood test to detect a cancer that begins in the colon or rectum. The panel ...
Ipilimumab, a Pioneer Breakthrough in Cancer Treatment
Forbes· 4 日前In 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was ...